Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2 - PubMed (original) (raw)

. 2004 May 1;109(5):698-702.

doi: 10.1002/ijc.20038.

Affiliations

• PMID: 14999777
• DOI: 10.1002/ijc.20038

Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2

Wenbin Ma et al. Int J Cancer. 2004.

Abstract

We have identified 2 antigens recognized by several melanoma-specific cytolytic T lymphocyte clones isolated from a melanoma patient with a clinical history of tumor regression after immunotherapy. Both antigens are presented by HLA-A2 and encoded by gene MAGE-C2, a cancer-germline gene shown previously to be silent in normal somatic tissues and expressed in 40% of melanomas and in other tumor types. One antigen corresponds to peptide ALKDVEERV(336-344), whereas the other corresponds to peptide LLFGLALIEV(191-200). The CTL clones recognizing these 2 peptides also recognized allogeneic tumor cell lines expressing MAGE-C2 and HLA-A2. These 2 new peptides are the first known MAGE-C antigens and represent promising targets for cancer immunotherapy.

Copyright 2004 Wiley-Liss, Inc.

PubMed Disclaimer

Similar articles

• A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
  van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A, Boon T. van der Bruggen P, et al. Eur J Immunol. 1994 Dec;24(12):3038-43. doi: 10.1002/eji.1830241218. Eur J Immunol. 1994. PMID: 7805731
• Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
  Valmori D, Liénard D, Waanders G, Rimoldi D, Cerottini JC, Romero P. Valmori D, et al. Cancer Res. 1997 Feb 15;57(4):735-41. Cancer Res. 1997. PMID: 9044853
• A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.
  Schiavetti F, Thonnard J, Colau D, Boon T, Coulie PG. Schiavetti F, et al. Cancer Res. 2002 Oct 1;62(19):5510-6. Cancer Res. 2002. PMID: 12359761
• Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
  Coulie PG, Weynants P, Lehmann F, Herman J, Brichard V, Wölfel T, Van Pel A, De Plaen E, Brasseur F, Boon T. Coulie PG, et al. J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):104-9. doi: 10.1097/00002371-199308000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8280701 Review.
• Tumor antigens recognized by T lymphocytes.
  Van den Eynde BJ, Boon T. Van den Eynde BJ, et al. Int J Clin Lab Res. 1997;27(2):81-6. doi: 10.1007/BF02912440. Int J Clin Lab Res. 1997. PMID: 9266277 Review.

Cited by

• Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens.
  Schossig P, Coskun E, Arsenic R, Horst D, Sehouli J, Bergmann E, Andresen N, Sigler C, Busse A, Keller U, Ochsenreither S. Schossig P, et al. Int J Mol Sci. 2023 Jan 24;24(3):2292. doi: 10.3390/ijms24032292. Int J Mol Sci. 2023. PMID: 36768616 Free PMC article.
• Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.
  Alarcon NO, Jaramillo M, Mansour HM, Sun B. Alarcon NO, et al. Pharmaceutics. 2022 Jul 11;14(7):1448. doi: 10.3390/pharmaceutics14071448. Pharmaceutics. 2022. PMID: 35890342 Free PMC article. Review.
• An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool.
  Verkerk T, Koomen SJI, Fuchs KJ, Griffioen M, Spaapen RM. Verkerk T, et al. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2119736119. doi: 10.1073/pnas.2119736119. Epub 2022 Jul 8. Proc Natl Acad Sci U S A. 2022. PMID: 35858315 Free PMC article.
• POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.
  Meng Q, Wu Y, Sui X, Meng J, Wang T, Lin Y, Wang Z, Zhou X, Qi Y, Du J, Gao Y. Meng Q, et al. Front Immunol. 2020 Oct 7;11:02193. doi: 10.3389/fimmu.2020.02193. eCollection 2020. Front Immunol. 2020. PMID: 33133063 Free PMC article.
• Integration of IgA and IgG Autoantigens Improves Performance of Biomarker Panels for Early Diagnosis of Lung Cancer.
  Pan J, Yu L, Wu Q, Lin X, Liu S, Hu S, Rosa C, Eichinger D, Pino I, Zhu H, Qian J, Huang Y. Pan J, et al. Mol Cell Proteomics. 2020 Mar;19(3):490-500. doi: 10.1074/mcp.RA119.001905. Epub 2020 Jan 10. Mol Cell Proteomics. 2020. PMID: 31924693 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • Cellosaurus - a cell line knowledge resource
  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal